FDA issues Guidance for a clear Identification of pharmaceutical Companies

In our GMP News from September 2013 you learned about a draft of a FDA Guidance for Industry entitled "Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration". This document's goal was to clearly identify pharmaceutical sites. The draft comprised (manageable) five pages - including the cover page. And in terms of volume this didn't change. However, some of the alternatives still mentioned in the draft, are not stated any longer - as one can find out when contacting the authority in these cases. The method now wanted is a registration by a D-U-N-S- (Data Universal Numbering System) number. This number - which is a 9-digit code - is supplied by the company Dun & Bradstreet.

To find out more please see the complete Guidance for Industry "Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration". 

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK